Literature DB >> 2137641

Plasminogen activators: pharmacology and therapy.

R W Holden1.   

Abstract

Biochemical advances are providing new insights into coagulation and fibrinolysis. Integrating this biochemical knowledge into plasminogen activator therapy improves understanding of currently available enzymes. Basic components of the fibrinolytic system are discussed and the chemical structures, pharmacokinetics, dosages, and modes of delivery of current and future plasminogen activators are reviewed.

Mesh：

Substances：

Year:  1990        PMID： 2137641     DOI： 10.1148/radiology.174.3.174-3-993

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  8 in total

1.  Purification and partial characterization of a chymotrypsin-like serine fibrinolytic enzyme from Bacillus amyloliquefaciens FCF-11 using corn husk as a novel substrate.

Authors:  Essam Kotb
Journal:  World J Microbiol Biotechnol       Date:  2014-03-08       Impact factor: 3.312

2.  Fibrinolysis and anticoagulant potential of a metallo protease produced by Bacillus subtilis K42.

Authors:  Wesam A Hassanein; Essam Kotb; Nadia M Awny; Yehia A El-Zawahry
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

Review 3.  Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature.

Authors:  J Hartmann; A Hussein; E Trowitzsch; J Becker; K H Hennecke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

Review 4.  Catheter-directed interventions for pulmonary embolism.

Authors:  Mehrzad Zarghouni; Hearns W Charles; Thomas S Maldonado; Amy R Deipolyi
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

5.  Extended infusion of rtPA lysis of pulmonary emboli: influence of time after onset of symptoms on outcome.

Authors:  M Aschauer; E Pilger; D H Szolar; F Flueckiger; K Hausegger; G Stark; R Groell; G E Klein; H Schreyer
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Sep-Oct       Impact factor: 2.740

6.  The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism.

Authors:  Yaşar Demirelli; Kadir Şerafettin Tekgündüz; İbrahim Caner; Mustafa Kara
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

7.  Bio-prospecting of cuttle fish waste and cow dung for the production of fibrinolytic enzyme from Bacillus cereus IND5 in solid state fermentation.

Authors:  Gurupatham Devadhasan Biji; Arumugaperumal Arun; Eswaran Muthulakshmi; Ponnuswamy Vijayaraghavan; Mariadhas Valan Arasu; Naif Abdullah Al-Dhabi
Journal:  3 Biotech       Date:  2016-10-28       Impact factor: 2.406

Review 8.  Ultrasound-responsive polymer-based drug delivery systems.

Authors:  Ping Wei; Erik Jan Cornel; Jianzhong Du
Journal:  Drug Deliv Transl Res       Date:  2021-03-24       Impact factor: 4.617
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.